Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Similarly, Brigham Buhler of Ways2Well claims to have put 75,000+ patients on peptides, across their practices, with no reported adverse events
For most patients in standard medically supervised programs, 2.4 mg remains the target maintenance dose
Our team provides continuous support, monitoring your progress and providing the education needed to master your metabolism
Whether a 64mg pen is necessary depends on study duration and dose escalation
Lilly PACKAGE LABEL - Zepbound Multi-Dose Vial - 10 mg/0.6 mL Dose (40 mg/2.4 mL [16.7 mg/mL]) PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Rx Only NDC 0002-6304-11 Zepbound (tirzepatide) injection 40 mg/2.4 mL (16.7 mg/mL) ATTENTION: Contains 4 doses of 10 mg/0.6 mL 2.4 mL MULTI-DOSE VIAL For Subcutaneous Use Needles and Syringes are not included Dispense enclosed Medication Guide to each patient
